Effects of Empagliflozin on Risk for Cardiovascular Death and Heart Failure Hospitalization Across the Spectrum of Heart Failure Risk in the EMPA-REG OUTCOME® Trial.
Document Type
Journal Article
Publication Date
8-28-2017
Journal
European Heart Journal
DOI
10.1093/eurheartj/ehx511
APA Citation
Fitchett, D., Butler, J., van de Borne, P., Zinman, B., Lachin, J., Wanner, C., Woerle, H., Hantel, S., George, J., Johansen, O., & Inzucchi, S. (2017). Effects of Empagliflozin on Risk for Cardiovascular Death and Heart Failure Hospitalization Across the Spectrum of Heart Failure Risk in the EMPA-REG OUTCOME® Trial.. European Heart Journal, (). http://dx.doi.org/10.1093/eurheartj/ehx511
Peer Reviewed
1
